CHINA PHARMA HOLDINGS, INC. Stock Option, Exercise Price, Increase
CHINA PHARMA HOLDINGS, INC. (CPHI) had Stock Option, Exercise Price, Increase of $28.00 per share as of 2022-10-04, per its 10-K filed 2024-04-01.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceIncrease · last filed 2024-04-01
- 2022-10-04: Stock Option, Exercise Price, Increase $28.00; Stock Option, Exercise Price, Increase as first filed $5.60.
- 2021-09-09: Stock Option, Exercise Price, Increase $73.70; Stock Option, Exercise Price, Increase as first filed $1.47; Stock Option, Exercise Price, Increase 0 month $14.70; Stock Option, Exercise Price, Increase 0 month as first filed $1.47.
| Period end | Stock Option, Exercise Price, Increase | Stock Option, Exercise Price, Increase as first filed | Stock Option, Exercise Price, Increase 0 month | Stock Option, Exercise Price, Increase 0 month as first filed |
|---|---|---|---|---|
| 2022-10-04 | $28.00 10-K · filed 2024-04-01 | $5.60 10-K · filed 2023-03-30 | ||
| 2021-09-09 | $73.70 10-K · filed 2024-04-01 | $1.47 10-Q · filed 2021-11-12 | $14.70 10-K · filed 2023-03-30 | $1.47 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |